Login:
 
Savill P. Novel bleeding risk score for atrial fibrillation patients treated with DOACsPractitioner March 2022;266(1856):7

Novel bleeding risk score for atrial fibrillation patients treated with DOACs

25 Mar 2022Registered users

A new, simple risk score for predicting major bleeding in patients with nonvalvular atrial fibrillation treated with direct acting oral anticoagulants (DOACs) has been developed by researchers in Israel.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.